Table 1.
Demographics of study population.
| Primary site | Pancreas | Gastrointestinal tract (ileum, stomach, and appendix) | Total |
|---|---|---|---|
| Number of pts | 37 | 27 | 64 (M: 26) |
| Age median (range) | 59.5 (30–79) | 57 (21–78) | 59 (21–79) |
| Syndrome | 9 insulinoma | — | 9 insulinoma |
| 1 carcinoid syndrome | 2 carcinoid syndrome | 3 carcinoid syndrome | |
| 1 ZES | 1 ZES | 2 ZES | |
| Stage | I-II: 22 | I-II: 10 | I-II: 32 |
| IIIB-IV: 15 | IIIB-IV: 17 | IIIB-IV: 32 | |
| Ki67 median (range) | 1.8% (0.1–18.8%) | 2.3% (0.5–12.4%) | 1.8% (0.1–18.8%) |
| Grading | G1: 21 (56.8%) | G1: 18 (66.7%) | G1: 39 (60.9%) |
| G2: 16 (43.2%) | G2: 9 (33.3%) | G2: 25 (39.1%) | |
| Follow-up | Median 69.5 months (range: 4–140 months) | ||
ZES: Zollinger-Ellison syndrome.